ARS Pharmaceuticals Inc (NASDAQ:SPRY) shares, rose in value on Wednesday, February 12, with the stock price up by 0.69% to the previous day’s close as strong demand from buyers drove the stock to $11.63.
Actively observing the price movement in the last trading, the stock closed the session at $11.55, falling within a range of $11.26 and $11.77. Referring to stock’s 52-week performance, its high was $18.51, and the low was $6.70. On the whole, SPRY has fluctuated by 3.29% over the past month.
With the market capitalization of ARS Pharmaceuticals Inc currently standing at about $1.13 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 18.04M, with a low estimate of 3.4M and a high estimate of 56.5M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 15.46M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SPRY’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of SPRY currently trading nearly -10.52% and -6.11% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.72, while the 7-day volatility ratio is showing 7.20% which for the 30-day chart, stands at 7.31%. Furthermore, ARS Pharmaceuticals Inc (SPRY)’s beta value is 1.00, and its average true range (ATR) is 0.88.
A comparison of ARS Pharmaceuticals Inc (SPRY) with its peers suggests the former has fared considerably weaker in the market. SPRY showed an intraday change of 0.69% in last session, and over the past year, it grew by 64.27%%.
Data on historical trading for ARS Pharmaceuticals Inc (NASDAQ:SPRY) indicates that the trading volumes over the past 10 days have averaged 1.24 and over the past 3 months, they’ve averaged 1.31 million. According to company’s latest data on outstanding shares, there are 97.15 million shares outstanding.
Nearly 48.04% of ARS Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 44.34% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 14.67 million shares as on 2025-01-31, resulting in a short ratio of 10.59. According to the data, the short interest in ARS Pharmaceuticals Inc (SPRY) stood at 2838.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 13.68 million. The stock has risen by 10.24% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SPRY stock heading into the next quarter.
